Breathe Clear Institute

What Breathe Clear Institute does

Breathe Clear Institute is a privately held, single-site otolaryngology and allergy medical practice headquartered in Torrance, California. Founded by board-certified otolaryngologist Dr. Steven Davis, the practice diagnoses and treats ear, nose, throat, sinus, allergy, and sleep-related conditions across pediatric and adult patients in the South Bay region of Los Angeles. Beyond core ENT visits and allergy immunotherapy (shots and sublingual drops), the practice offers an unusually deep in-office procedure portfolio — Balloon Sinuplasty, SINUVA spacer insertion, Latera absorbable implant, RhinAer, Neuromark, ClariFix, Vivaer, turbinate reduction, balloon Eustachian tube dilation, and endoscopic sinus surgery — supported by in-office low-dose CT imaging and same-day skin allergy testing for 40 allergens.

Operationally the practice is a multi-payer medical group with two board-certified otolaryngologists (Davis, Mathur), two ENT-specialized physician assistants, dedicated allergy technicians, and practice administration including a 23-year healthcare veteran practice administrator. Revenue is generated primarily through insurance reimbursement (most major PPO plans plus Medicare and Tricare), an HMO channel via Providence Medical Associates IPA, out-of-pocket cash pay for uninsured or out-of-network patients, and incremental research revenue from participating as a site in three active clinical trials (NEUROMARK for chronic rhinosinusitis, CONTRAST-NP for chronic rhinosinusitis with nasal polyps, Ibuzatrelvir for COVID-19).

The go-to-market is direct-to-consumer for the South Bay corridor: a content-heavy website (80+ blog articles) plus location-specific SEO across nine South Bay sub-markets, supplemented by patient testimonials, an Instagram presence, and a formal provider-referral intake channel. No external investors, parent companies, M&A activity, or funding rounds are disclosed; growth has been funded organically through practice operations. No AI/ML or proprietary software platform is described — the practice's technical differentiation rests on specialty devices, integrated ENT+allergy clinical workflow, and concentrated sub-market brand equity rather than technology IP.

Name

Breathe Clear Institute

Legal name

THE BREATHE CLEAR INSTITUTE

Website

https://breatheclearinstitute.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Breathe Clear Institute is a private Torrance, California otolaryngology and allergy practice that diagnoses and treats ear, nose, throat, sinus, allergy, and sleep conditions for pediatric and adult patients across South Bay Los Angeles, offering in-office procedures and clinical trial participation.

Ownership category

akta.pro rank

Product category

ENT and Allergy Medical Services

NAICS

Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111), Offices of Other Health Practitioners (6213)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

General Otolaryngology (ENT) (HLAKAMAA)

akta.pro secondary industries

Asthma & Airway Disease Specialty Care (HLAKAAAC), Sleep Surgery & Snoring (ENT) (HLAKAMAH), Pediatric Otolaryngology (HLAKAMAB), Otology & Neurotology (Ear/Hearing/Balance) (HLAKAMAC)

Keywords

• ENT medical services
• Allergy treatment
• Sinus surgery
• Otolaryngology practice
• Allergy immunotherapy

Headquarters

HQ city

Torrance

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Consultation and Treatment Services: Revenue generated from patient consultations, diagnostic services, in-office procedures, and surgical treatments. Billed through insurance (PPO/HMO) or direct payment for uninsured patients. Services include ENT examinations, allergy testing, sinus treatments, sleep disorder evaluations, and surgical procedures.
2. Clinical Trial Participation: Participation in clinical trials for new medications and medical devices, potentially generating revenue through research grants and study compensation.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Breathe Clear Institute is a Torrance, California-based ENT (otolaryngology) and allergy medical practice that diagnoses and treats ear, nose, throat, sinus, allergy, and sleep conditions for pediatric and adult patients. The practice delivers comprehensive care including in-office diagnostics (low-dose sinus CT, skin allergy testing, flexible laryngoscopy), minimally invasive in-office procedures (Balloon Sinuplasty, SINUVA, Latera, RhinAer, Neuromark, ClariFix, Vivaer), and traditional surgery (Endoscopic Sinus Surgery, Septoplasty, Tonsillectomy, Adenoidectomy), supported by allergy immunotherapy (shots and sublingual drops).

Product overview

Breathe Clear Institute is a medical practice offering ENT (Ear, Nose, and Throat) and allergy services through a unified clinic model. The practice provides a comprehensive range of treatments including surgical procedures (Balloon Sinuplasty, Endoscopic Sinus Surgery, Septoplasty, Tonsillectomy), in-office treatments (SINUVA implant, Latera implant, RhinAer, ClariFix, Vivaer, Turbinate Reduction, Neuromark), and allergy services (Allergy Testing, Allergy Shots, Allergy Drops). Dr. Steven Davis serves as Medical Director alongside Dr. Supriya Mathur, with support from Physician Assistants. The practice also conducts clinical trials and provides diagnostic services including flexible laryngoscopy and in-office CT imaging.

Differentiator

Problem solved

Functional benefit

Products and services

• Balloon Sinuplasty Minimally invasive in-office procedure using a small balloon catheter inserted into sinus passages to widen blocked drainage pathways and relieve chronic sinusitis symptoms; performed under local anesthesia with a quick recovery time of approximately 48 hours.
• SINUVA Spacer Insertion Bioabsorbable, steroid-releasing nasal implant for adults with recurring nasal polyps after endoscopic sinus surgery; delivers mometasone furoate directly to sinus tissue for up to 90 days.
• Endoscopic Sinus Surgery (ESS) Minimally invasive surgical procedure using a nasal endoscope to visualize and open blocked sinus passages, remove polyps, and improve sinus drainage for chronic sinusitis and related conditions.
• Latera Self-Dissolving Implant Placement FDA-approved absorbable PLLA polymer nasal implant placed into the lateral nasal wall to prevent collapse during breathing; dissolves over 18-24 months while stimulating ongoing tissue support.
• RhinAer Treatment that disrupts abnormal signals in the nose to relieve symptoms of chronic rhinitis.
• ClariFix Treatment for chronic rhinitis, chronically drippy nose, excessive throat clearing, and postnasal drip.
• Vivaer Procedure that increases airflow through the internal nasal valve to treat nasal obstruction.
• Neuromark Non-invasive handheld medical device that delivers energy to the inside of the nose to interrupt nasal nerves and reduce symptoms related to Chronic Rhinitis and Chronic Rhinosinusitis.
• Turbinate Reduction Procedure to reduce enlarged turbinates within the nose using Coblation (radiofrequency) or submucosal resection to restore airflow and relieve chronic congestion.
• Septoplasty Surgical procedure to correct a deviated septum by straightening and repositioning the bone and cartilage that divides the nostrils.
• Tonsillectomy Surgical removal of the tonsils to treat sleep disorders, breathing problems, or tonsillitis that does not respond to medical treatments.
• Adenoidectomy Surgical removal of adenoids (soft tissue pads in the back of the nose) for children and some adults experiencing nasal congestion.
• Uvulopalatopharyngoplasty (UPPP) Surgical treatment for obstructive sleep apnea that remodels tissue at the back of the throat to help open up the airway.
• Radiofrequency Ablation of the Soft Palate Procedure that tightens and shrinks soft palate tissue to improve sleep quality and reduce snoring and sleep apnea.
• Myringotomy With or Without Tube Placement Surgical procedure to relieve pressure and allow drainage from the middle ear, with or without tube placement, for adults and children.
• Sophono Hearing System Magnetic bone-anchored hearing system (BAHS) recommended for children and adults with unilateral deafness or hearing loss in one ear.
• Allergy Shots Subcutaneous immunotherapy injections for environmental allergies that can cure patients of their allergies over time; administered twice weekly during the build-up phase.
• Allergy Drops (Sublingual Immunotherapy) Needle-free sublingual immunotherapy in which patients place drops under the tongue daily at home to develop allergy tolerance over 3-5 years.
• Allergy Testing Skin allergy testing for 40 different allergens with same-day results, safe for both adults and children.
• Flexible Laryngoscopy Diagnostic procedure using a flexible scope to examine the ear, nose, and throat, preferred for patient comfort and broader upper airway visualization.
• In-Office Sinus CT Imaging Low-dose in-office sinus CT scanning with same-day image review and diagnosis during the initial consultation, eliminating the need for an outside imaging center.
• Balloon Dilation of the Eustachian Tube Treatment for Eustachian tube dysfunction using the Aera Balloon to relieve hearing loss or sensation of pressure or a clogged ear.
• Epley Maneuver Canalith Repositioning Maneuver that relieves benign positional vertigo through a 10-15 minute in-office session.
• Earwax Removal Removal of excess earwax buildup that can lead to fullness, itching, partial hearing loss, and other symptoms.
• Clinical Trials Participation as a research site in clinical trials including NEUROMARK System for Chronic Rhinosinusitis, CONTRAST-NP for Chronic Rhinosinusitis with Nasal Polyps, and Ibuzatrelvir for COVID-19 in non-hospitalized patients at risk for severe disease.

Quantifiable outcome

• Most patients return to normal activity within 48 hours after balloon sinuplasty
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Providence Medical Associates IPAcoreChannel Partner/ Reseller/ DistributorHMO network partnership through which Breathe Clear Institute provides ENT services to Providence Medical Associates IPA patients. Listed as Axminster IPA in insurance documentation.
• NEUROMARK System (Neuromark Clinical Study)coreStrategic or Co-development PartnerClinical study of the NEUROMARK System in patients with Chronic Rhinosinusitis (CRS). Practice participates as a research site for this investigational medical device study.
• CONTRAST-NP Research StudycoreStrategic or Co-development PartnerResearch study assessing an investigational medicine for Chronic Rhinosinusitis with Nasal Polyps. Practice serves as a clinical research site.
• Ibuzatrelvir COVID-19 StudyminorStrategic or Co-development PartnerClinical study of Ibuzatrelvir in adult and adolescent patients with COVID-19 who are not hospitalized but at risk for severe disease.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Aspire Allergy & Sinus: Multi-location allergy and sinus clinic chain offering allergy testing, immunotherapy, and in-office sinus procedures. Directly comparable to BCI in service mix, direct-to-consumer GTM motion, and condition focus.
• US ENT Partners: ENT specialty practice aggregation platform partnering with independent otolaryngology groups. BCI would be a logical target for this type of roll-up given its integrated ENT + allergy model.
• Enticare ENT: Multi-provider ENT and allergy practice offering comparable in-office procedures (balloon sinuplasty, allergy testing, sinus surgery) and direct-to-consumer patient acquisition. Closely matches BCI's clinical scope and patient mix.
• Allervie Health (formerly AllerVie): National allergy and asthma practice platform offering allergy testing, immunotherapy, and asthma care. Direct comparable on the allergy side of BCI's offering.

Regional players

• Houston Ear Nose Throat & Allergy: Independent ENT and allergy practice in Houston offering a similar service mix (sinus, allergy, sleep, hearing). Operates in a different geography but is structurally and operationally comparable to BCI.

Emerging players

• Aerin Medical: Manufacturer of RhinAer and VivAer — both offered at BCI. Comparable in category (ENT energy-based device) and has overlap on the chronic rhinitis and nasal obstruction segments that BCI treats.

Broad incumbents

• Medtronic (ENT): Large medical device incumbent whose ENT/sinus surgery portfolio (e.g., NuVent, StealthStation, imaging) underpins much of the procedural work ENT practices like BCI perform. Comparable as a counterparty and as a benchmark for ENT care delivery.
• Stryker (ENT Instruments): Diversified medical device company with a meaningful ENT and surgical instruments portfolio. Comparable as a major supplier of the instrumentation used in BCI's sinus and ENT surgical procedures.

Others

• Providence Medical Institute: Integrated delivery network partner of BCI through the Providence Medical Associates IPA. Comparable as a network counterparty and as a benchmark for value-based specialty care models BCI could migrate toward.
• Healow (eClinicalWorks): Patient engagement and scheduling platform used by BCI for online appointment booking, patient portal, and payments. Comparable as the technology backbone of BCI's direct-to-consumer GTM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/breatheclear
• Facebookfacebook.com/breatheclearinstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Breathe Clear Institute